Randall Kaye - 21 Mar 2022 Form 4 Insider Report for Longboard Pharmaceuticals, Inc.

Role
CMO
Signature
/s/ Brandi L. Roberts, Attorney-In-Fact
Issuer symbol
N/A
Transactions as of
21 Mar 2022
Net transactions value
$0
Form type
4
Filing time
21 Mar 2022, 17:18:04 UTC
Next filing
10 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LBPH Stock Option (Right to Buy) Award $0 +206,500 $0.000000 206,500 21 Mar 2022 Voting common stock 206,500 $6.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares subject to the stock option vest on March 21, 2023, and the remaining shares vest in 36 equal monthly installments thereafter.